A Prospective, Multicenter, Phase III Clinical Evaluation of the Safety and Efficacy of NH002 as a Contrast Agent Administrated Via Intravenous Bolus Injection and Infusion for Subjects Undergoing Cardiac Echocardiography

Clinical trial NCT07740421 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07740421
Sponsor: Trust Bio-sonics, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cardiac Diseases

Start date: 2026-07-01
Primary completion: 2027-07-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.